Shares of genetic data healthcare company 23andMe (NASDAQ: ME) jumped higher on Monday morning, as did many other beaten-down stocks. It seems the market is willing to take a bet on this stock before the company reports financial results today after the market closes. 23andMe is scheduled to report financial results for the first quarter of its fiscal 2023 today after the market closes, followed by a conference call at 4:30 p.m. ET.
Yahoo Finance’s Ines Ferré joins the Live show to break down how stocks are performing after the June jobs report was released.
The stock market was experiencing a frothy Friday on the last trading day of the week, but 23andMe Holding (NASDAQ: ME) was a bit of a wallflower at the party. As of 1:30 p.m. ET , the genetic testing and research specialist's shares were up only incrementally, at a rate well behind the S&P 500 index's 1.7% gain. For 23andMe's fourth quarter of fiscal 2022, the company recorded just under $101 million in revenue, which was 14% higher than the same period of the previous year.